We are live on !
Find out more
HighMark Wealth Management Portfolio holdings
AUM
$299M
Turnover
13.67%
1-Year Est. Return
53.01%
This Fund
S&P 500
This Quarter Est. Return
+21.77%
1 Year Est. Return
+53.01%
3 Year Est. Return
+109.68%
5 Year Est. Return
+113.63%
10 Year Est. Return
–
AUM
$299M
AUM Growth
+$52.9M
(+22%)
Cap. Flow
+$8.26M
Cap. Flow % of AUM
Cap. Flow %
2.77%
Top 10 Holdings %
Top 10 Hldgs %
65.82%
Holding
600
New
46
Increased
156
Reduced
94
Closed
36
Avg Time Held
Equity + Options
3.4
years
Top 10 Avg Time Held
Equity + Options
2.7
years
Top 20 Avg Time Held
Equity + Options
2.3
years
Avg Time Held Equity only
3.4
years
Top 10 Avg Time Held Equity only
2.7
years
Top 20 Avg Time Held Equity only
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity MSCI Health Care Index ETF
FHLC
|
+$18.3M |
| 2 |
SI-BONE Inc
SIBN
|
+$3.79M |
| 3 |
Duos Technologies
DUOT
|
+$2.91M |
| 4 |
Apogee Therapeutics
APGE
|
+$2.91M |
| 5 |
Neuropace
NPCE
|
+$1.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$9.41M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$5.14M |
| 3 |
AnaptysBio
ANAB
|
+$3.29M |
| 4 |
iShares MSCI EAFE Value ETF
EFV
|
+$1.64M |
| 5 |
Piper Sandler
PIPR
|
+$1.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 64.9% |
| 2 | Healthcare | 21.84% |
| 3 | Technology | 4.77% |
| 4 | Financials | 3.58% |
| 5 | Industrials | 1.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
TWO
301
DELISTED
Two Harbors Investment
TWO
| $11.4K | ﹤0.01% |
919
+27
| +3% | +$323 |
2020 Q2
24 quarters
|
|
302
ARK Next Generation Technology ETF
ARKW
$1.45B
| $11.3K | ﹤0.01% |
78
| – | – |
2025 Q2
4 quarters
|
|
303
Wheaton Precious Metals
WPM
$60.2B
| $11.3K | ﹤0.01% |
100
| – | – |
2020 Q1
25 quarters
|
|
304
Charles Schwab
SCHW
$160B
| $11.3K | ﹤0.01% |
122
-30
| -20% | -$2.74K |
2021 Q2
20 quarters
|
|
305
Duke Energy
DUK
$102B
| $11K | ﹤0.01% |
87
+50
| +135% | +$6.31K |
2024 Q2
8 quarters
|
|
306
Linde
LIN
$239B
| $10.9K | ﹤0.01% |
21
| – | – |
2022 Q3
15 quarters
|
|
307
Emerson Electric
EMR
$90.7B
| $10.9K | ﹤0.01% |
76
+5
| +7% | +$704 |
2024 Q1
9 quarters
|
|
308
Fidelity Wise Origin Bitcoin Fund
FBTC
$14.1B
| $10.9K | ﹤0.01% |
213
+25
| +13% | +$1.56K |
2024 Q1
9 quarters
|
|
309
American Express
AXP
$218B
| $10.8K | ﹤0.01% |
32
| – | – |
2020 Q3
23 quarters
|
|
310
Vanguard Energy ETF
VDE
$10.3B
| $10.8K | ﹤0.01% |
72
+1
| +1% | +$162 |
2023 Q4
10 quarters
|
|
311
BrightSpring Health Services
BTSG
$13.1B
| $10.5K | ﹤0.01% |
150
| – | – |
2026 Q1
1 quarter
|
|
|
312
Piper Sandler
PIPR
$4.75B
| $10.4K | ﹤0.01% |
143
-15,605
| -99% | -$1.27M |
2025 Q2
4 quarters
|
|
313
Geron
GERN
$610M
| $10.3K | ﹤0.01% |
8,025
+500
| +7% | +$704 |
2023 Q1
13 quarters
|
|
314
iShares MSCI USA Quality Factor ETF
QUAL
$11.8B
| $10.2K | ﹤0.01% |
188
+4
| +2% | +$210 |
2025 Q2
4 quarters
|
|
315
Rocket Lab Corp
RKLB
$29.4B
| $10.2K | ﹤0.01% |
100
| – | – |
2025 Q2
4 quarters
|
|
316
AdvisorShares Pure US Cannabis ETF
MSOS
$764M
| $10.2K | ﹤0.01% |
2,000
| – | – |
2025 Q2
4 quarters
|
|
317
Stevanato
STVN
$3.6B
| $10K | ﹤0.01% |
552
| – | – |
2024 Q2
8 quarters
|
|
318
Ball Corp
BALL
$17.7B
| $9.9K | ﹤0.01% |
159
| – | – |
2023 Q1
13 quarters
|
|
319
JPMorgan Chase
JPM
$896B
| $9.8K | ﹤0.01% |
+30
| New | +$9.32K |
2026 Q2
0 quarters
|
|
320
MetLife
MET
$63.4B
| $9.7K | ﹤0.01% |
+115
| New | +$9.28K |
2026 Q2
0 quarters
|
|
321
PENN Entertainment
PENN
$2.32B
| $9.7K | ﹤0.01% |
455
-50
| -10% | -$896 |
2020 Q1
25 quarters
|
|
322
Howmet Aerospace
HWM
$79.9B
| $9.7K | ﹤0.01% |
36
-5
| -12% | -$1.28K |
2024 Q2
8 quarters
|
|
323
Blackrock
BLK
$181B
| $9.6K | ﹤0.01% |
+10
| New | +$10.3K |
2026 Q2
0 quarters
|
|
324
Phillips 66
PSX
$96.3B
| $9.47K | ﹤0.01% |
56
+22
| +65% | +$3.79K |
2026 Q1
1 quarter
|
|
325
Yum China
YUMC
$16.7B
| $9.41K | ﹤0.01% |
230
+1
| +0.4% | +$46 |
2019 Q4
26 quarters
|
|
Similar funds
BOC
HighMark Wealth Management's Q2 2026 Portfolio in Review
As of Q2 2026, HighMark Wealth Management held 600 positions worth $299M, up 22% from $246M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
HighMark Wealth Management's Q2 2026 filing shows 46 new, 156 increased, 94 reduced and 36 closed positions. Its largest new stake was Duos Technologies: 289,884 shares worth $3.48M. The largest sale was Centessa Pharmaceuticals, an estimated $9.41M.
By sector, the portfolio is most concentrated in Miscellaneous at 65% of assets, down from 65% a quarter earlier, followed by Healthcare and Technology.
- HighMark Wealth Management's largest Q2 2026 buy was Duos Technologies: 289,884 shares worth $3.48M.
- HighMark Wealth Management added most to Fidelity MSCI Health Care Index ETF in Q2 2026, an estimated $18.3M increase.
- HighMark Wealth Management's biggest Q2 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $5.14M.
- HighMark Wealth Management fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $9.41M.
- HighMark Wealth Management's ten largest holdings make up 66% of its $299M portfolio in Q2 2026.
- HighMark Wealth Management opened 46 new positions and closed 36 in Q2 2026.
- HighMark Wealth Management's portfolio value rose 22% quarter-over-quarter to $299M.
Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.